Tag Archives: XLV

S&P Rally Attempt Failed At Formidable Resistance

Editor’s note: this column was originally published on Capital Essence’s CEM News. It’s being republished as a bonus for the loyal readers. For more information about subscribing to CEM News, please click here.

 

Good Morning, this is Capital Essence’s Market Outlook (the technical analysis of financial markets) for Monday October 19, 2020.

We’ve noted in the previous Market Outlook that: “the big picture remains the same. There is an orderly pullback consolidation, which represents digestion period.  However, the fact that buying pressure deteriorated as the S&P tested key price level suggested that most of the potential buyers at this level had already placed their bets.  The next batch of buyers typically sits at a much lower level.  With this in mind we’d look to reduce exposure into intraday bounces.”  As expected, S&P traded higher in early Friday session as investors cheers the stronger retail sales data before the late day selling pushed the index into the red. For the day, the bench mark gauge eked out a small gain, closing at 3,483.81.  The Dow Jones Industrial Average rose 0.4 percent to 28,606.31.  The Nasdaq Composite ended the day down 0.4 percent to 11,671.56.  The CBOE Volatility Index (VIX), widely considered the best gauge of fear in the market, rose more than 1 percent to 27.41.

Pfizer (PFE) said it would apply for emergency U.S. approval of its Covid-19 vaccine it is developing with Germany’s BioNTech in the third week of November. Pfizer and Biontech Se (BNTX) both added nearly 4 percent.  The news helped restore some optimism over a Covid-19 vaccine after both Eli Lilly and Company (LLY) and Johnson & Johnson (JNJ) announced setbacks earlier this week.  As such, the Health Care Select Sector SPDR Fund (XLV) rose 0.99 percent on the day and is up about 6 percent YTD, slightly underperformed the S&P.  Now the question is what’s next?  Below is an update look at a trade in XLV.

The graphics below are from our “U.S. Market Trading Map”, show the near-term technical bias and trading ranges.  As shown, the underlying is in a short-term bullish trend when the price bars are painted in green.  The underlying is in a short-term bearish trend when the price bars are painted in red.  The yellow bars identify period of neutral or sideways trading pattern.  Additionally, the light-blue shading represents the short-term trading range.  A move above or below that range is considered overbought (as represents by the red shading) or oversold (as represents by the dark-green shading).  Readings above or below the red and green shaded areas are considered extremely overbought or extremely oversold.

Chart 1.1 – Health Care Select Sector SPDR Fund (weekly)

Our “U.S. Market Trading Map” painted XLV bars in green (buy) – see area ‘A’ in the chart.  Over the past few weeks, XLV has been trending higher after the early September correction found support near the one-year moving average, a key technical level based on moving averages. This week’s rally pushed the ETF up against the closely watch 110 zone, or the prior high set in September.  The overall technical backdrop remains positive, providing support for further advance. Right now, the most important thing to watch is trading behavior near the 110 zone.  A close above that level on a weekly closing basis has measured move to around 130, or the 127.2% Fibonacci extension.

XLV has support near 105.  Short-term traders could use that level as the logical level to measure risk against.

Chart 1.2 – S&P 500 index (daily)

Short-term technical outlook remains bearish (sell).  Last changed October 15, 2020 from bullish (buy) – (see area ‘A’ in the chart).

[Note: for more details analysis, please take a look at our “US Market ETF Trading Map”]

S&P sold off after the early rally attempt ran out of steam near the important sentiment 3500 mark. That level was tested several times over the past months.  Technically speaking, the longer the index holds below this resistance the stronger it becomes.  Adding to concerns is Money Flow measure, which hovers near the zero line since market broke down in early September, indicating a weak net demand for stocks.  Right now, the most important thing to watch is the retreat and rebound behavior as the 3460 zone is tested as support.  A close below that level suggested that the next leg would be lower and we’re looking at 3400.

Short-term trading range: 3400 to 3600.  S&P has support around 3460.  A failure to hold above that level has measured move to around 3400.  Resistance is around 3500.  A sustain advance above that level has measured move to 3600.

Long-term trading range: 3150 to 3730.  S&P has support near 3350.  A failure to hold above that level has measured move to 3150.  The index has resistance near 3600.  A close above that level has measured move to 3900.

In summary, there is currently a test of resistance at the important sentiment 3500 mark.  If the S&P fails to climb above that level this week than the next stop will be 3400 with the possibility of a brief breakdown below that level.

 

Thanks and happy trading.

(By:Michelle Mai for Capital Essence)

© All rights reserved and actively enforced.
Note: This is a free edition of The Market Outlook, a daily CEM News subscriber newsletter. To get this column before market opens together with hundreds of technical trading ideas (including stocks and ETFs) every month, please click here.
Subscribe to CEM News to receive more in-depth research from Capital Essence.v